{
  "id": "biomarker-compliance-tat",
  "display_name": "Biomarker Testing Turnaround Time",
  "cohort": "Biomarker Testing, Turnaround Time Analysis (2024–2025)",
  "insight_type": "Precision Medicine Utilization",
  "summary": "Average biomarker testing turnaround time is 12.3 days, with significant variation by testing method and cancer type. Reducing average TAT by 5 days could generate $220,000 in additional value.",
  "chart": {
    "type": "bar",
    "unit": "method",
    "data": [
      { "name": "NGS Panel", "value": 18.4, "gap": 8.4, "highlight": true },
      { "name": "IHC", "value": 5.2, "gap": -4.8, "highlight": false },
      { "name": "FISH", "value": 6.8, "gap": -3.2, "highlight": false },
      { "name": "PCR", "value": 7.3, "gap": -2.7, "highlight": false },
      { "name": "Liquid Biopsy", "value": 8.7, "gap": -1.3, "highlight": false },
      { "name": "RNA-seq", "value": 15.6, "gap": 5.6, "highlight": true }
    ],
    "benchmark": 10,
    "nccn_target": 7
  },
  "financial_impact": {
    "annual_opportunity": "$220,000/year",
    "math": "$220,000/year = 5 day reduction in TAT × 85 patients × $520 per day in improved care value"
  },
  "clinical_impact": {
    "description": "Reducing biomarker testing turnaround time enables faster treatment initiation and improves outcomes.",
    "metrics": [
      {
        "type": "TTT",
        "value": "-8.4 days",
        "description": "Reduction in time to treatment initiation"
      },
      {
        "type": "OS",
        "value": "+3.2 months",
        "description": "Overall survival benefit with faster treatment initiation"
      },
      {
        "type": "LOS",
        "value": "-1.7 days",
        "description": "Reduced hospital length of stay"
      },
      {
        "type": "EOL",
        "value": "-22%",
        "description": "Reduced end-of-life care utilization"
      },
      {
        "type": "QoL",
        "value": "+18%",
        "description": "Improved quality of life with earlier treatment"
      }
    ],
    "quantitative": "-8.4 days TTT"
  },
  "peer_comparison": {
    "description": "Top performing practices achieve an average turnaround time of 6.8 days compared to your 12.3 days through integrated pathology systems.",
    "peer_benchmark": 6.8,
    "financial_impact": {
      "annual_opportunity": "$286,000/year",
      "math": "$286,000/year = 5.5 day reduction to match benchmark × 100 patients × $520 per day"
    },
    "action_steps": [
      {
        "text": "Implement rapid pathology workflow for NGS and RNA-seq testing",
        "icon": "clock"
      },
      {
        "text": "Develop TAT dashboard and alert system for delayed results",
        "icon": "chart"
      },
      {
        "text": "Establish courier system for expedited sample delivery",
        "icon": "truck"
      },
      {
        "text": "Create batching optimization protocols for sequencing runs",
        "icon": "cog"
      }
    ]
  },
  "weighted_score": 83,
  "action_steps": [
    {
      "text": "Implement weekly NGS panel batching to reduce delays",
      "icon": "calendar"
    },
    {
      "text": "Create TAT tracking system with automated alerts",
      "icon": "clock"
    },
    {
      "text": "Develop expedited pathway for high-risk patients",
      "icon": "flag"
    },
    {
      "text": "Establish standing molecular tumor board for rapid review",
      "icon": "users"
    }
  ],
  "suggestions": [
    {
      "text": "Consider partnership with rapid-TAT reference lab",
      "icon": "building"
    },
    {
      "text": "Implement parallel testing workflows where appropriate",
      "icon": "workflow"
    }
  ],
  "drilldowns": [
    {
      "label": "By Cancer Type",
      "cohort": "Biomarker Testing by Cancer Type",
      "jsonFile": "biomarker-compliance-by-cancer.json",
      "drilldownLevel": 1
    },
    {
      "label": "By Provider",
      "cohort": "Biomarker Testing by Provider",
      "jsonFile": "biomarker-compliance-by-provider.json",
      "drilldownLevel": 1
    },
    {
      "label": "By Site",
      "cohort": "Biomarker Testing by Site",
      "jsonFile": "biomarker-compliance-by-site.json",
      "drilldownLevel": 1
    },
    {
      "label": "Overall Compliance",
      "cohort": "Biomarker Testing Compliance",
      "jsonFile": "biomarker-compliance.json",
      "drilldownLevel": 0
    }
  ]
} 